Clinical trial
Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial…
NCT00232531 · University of Oxford, Other · Unknown status
Key facts
| NCT number | NCT00232531 |
|---|---|
| Title | Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function |
| Official title | Cardiovascular Magnetic Resonance Evaluation of the Effects of Niaspan on Regression of Atherosclerosis and Restoration of Endothelial Function |
| Lead sponsor | University of Oxford, Other |
| Collaborators | Merck KGaA, Darmstadt, Germany Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Atherosclerosis |
| Intervention type | Drug |
| Interventions | Niaspan |
| Enrollment | 70 |
| Start date | Sep 1, 2004 |
| Completion | Feb 1, 2009 |
| First posted | Oct 4, 2005 |
| Last update posted | Jan 29, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: